Dr. Tricia Y. Ting, MD

Dr. Tricia Y. Ting, MD

Dr. Tricia Y. Ting, MD

Languages: English, Chinese - Cantonese
Fax: (301) 215-4499

Contact this Provider:

Specialties
  • Neurology
  • Epilepsy
Conditions I Treat
  • abnormal eeg
  • absence epilepsy
  • atonic epilepsy
  • cryptogenic epilepsy
  • drop attack
  • Show All
Procedures I Perform
  • ambulatory eeg
  • electrodiagnostic medicine
  • electroencephalography
  • vagus nerve stimulation
  • wada testing
About the Provider

Tricia Ting, MD, is professor of neurology and regional director of epilepsy at MedStar Georgetown University Hospital. As regional director, her focus is to integrate epilepsy and EEG services across MedStar Health in order to bring the highest level of care to neurology patients in the Washington, D.C. and surrounding region.

Dr. Ting specializes in evaluating new onset seizures and caring for women with epilepsy. She has extensive experience in clinical trials of new drugs for epilepsy and seizure rescue therapies. Dr. Ting's current research is funded by the Food and Drug Administration (FDA) to answer a common concern of both patients and physicians, whether the action and safety of generic antiepileptic drugs is identical to brand-name medications in patients with epilepsy.

Individualizing care for every patient is central to Dr. Ting's philosophy of care at MedStar Georgetown. Her goal is to empower patients to optimize their seizure control by managing common risks and to minimize medication side effects. She works closely with patients to explore treatment options, including newer antiepileptic drugs.

Dr. Ting and the Departments of Neurology and Neurosurgery use an interdisciplinary approach to guide patients to their best treatment plan. The Epilepsy Monitoring Unit (EMU) at MedStar Georgetown is unique within the MedStar Health system. It is a specialized inpatient unit for evaluating and managing refractory seizures in adults and children. The EMU definitively diagnoses and localizes seizures by capturing them with simultaneous EEG brain wave recordings. An EMU evaluation is often the first step to determine if epilepsy surgery may be a treatment option for some patients with intractable seizures.

Videos
Education
  • Fellowship Program: University of Pennsylvania Hospitals (2000)
  • Internship/Residency: Albert Einstein Medical Center (1997)
  • Medical School: University of Pennsylvania School of Medicine (1996)
  • Board Certification: American Board of Psychiatry and Neurology, Neurology
Publications
  • Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard. Epilepsia. 2015;56:1415-1424.
  • American Academy of Neurology; American Epilepsy Society. Practice parameter update: management issues for women with epilepsy äóñ focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009 Jul 14; 73(2):126-32
  • Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007;69: 1996-2007
  • Uncertain value of electronic fetal monitoring in predicting cerebral palsy. New England Journal of Medicine.1996;334:613-618.
  • FDA Town Hall (Tricia Ting, Platform Presentation): "Exploring generic brittleness in epilepsy patients." AES Annual Meeting, Houston. December 5, 2016.
  • AES (American Epilepsy Society) Ask the Expert Webinar: "Use of Generic AEDs", Presenter: Tricia Ting MD, Moderator: Dennis J. Dlugos, M.D. May 10, 2016.
  • Medscape Interview of Dr. Ting by Bret S. Stetka, MD posted on-line. "How Pill Color Affects Drug Adherence". Medscape. May 09, 2016
Publications/Presentations

  • Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard. Epilepsia. 2015;56:1415-1424.
  • American Academy of Neurology; American Epilepsy Society. Practice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009 Jul 14; 73(2):126-32
  • Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007;69: 1996-2007
  • Uncertain value of electronic fetal monitoring in predicting cerebral palsy. New England Journal of Medicine.1996;334:613-618.
  • FDA Town Hall (Tricia Ting, Platform Presentation): "Exploring generic brittleness in epilepsy patients." AES Annual Meeting, Houston. December 5, 2016.
  • AES (American Epilepsy Society) Ask the Expert Webinar: "Use of Generic AEDs", Presenter: Tricia Ting MD, Moderator: Dennis J. Dlugos, M.D. May 10, 2016.
  • Medscape Interview of Dr. Ting by Bret S. Stetka, MD posted on-line. "How Pill Color Affects Drug Adherence". Medscape. May 09, 2016

Insurance


Practice Locations
  • 5454 Wisconsin Avenue
    Suite 1100
    Chevy Chase, MD 20815
    View Map

    Phone: (301) 215-9420
    Fax: (301) 215-4499

  • 3800 Reservoir Road Northwest
    Pasquerilla Healthcare Center 7th Fl Dept Neurology
    Washington, DC 20007
    View Map

    Phone: (202) 444-8525
    Fax: (877) 245-1499

Member of Medical Staff
  • MedStar Georgetown University Hospital
  • MedStar Montgomery Medical Center
  • MedStar Southern Maryland Hospital Center